Panome Bio

Panome Bio is a San Diego-based contract research organization (CRO) offering end-to-end multi-omics services, leveraging proprietary AI/machine learning platforms to analyze metabolomics, proteomics, and transcriptomics data. The company differentiates itself with its 'Next-Generation Metabolomics' technology, MassID™, which uses a large compound database and computational workflows for confident metabolite identification. It operates a service-based business model, providing data analysis and reports to academic, biopharma, and other research clients, positioning itself as a discovery partner in the growing multi-omics and exposomics markets.

Proprietary 'Next-Generation Metabolomics' platform centered on the MassID™ machine-learning engine for metabolite identification from a 280k+ compound database, integrated with Discovery Proteomics and Transcriptomics services via a custom multi-omics bioinformatics pipeline.

Panome competes in a crowded multi-omics services market against large global CROs (e.g., Charles River, LabCorp, Eurofins), specialized omics firms (e.g., Metabolon, Olink, SomaLogic), and university core facilities. Its differentiation hinges on its untargeted metabolomics ID platform and integrated multi-omics analysis, rather than competing solely on price or throughput.